Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127239) titled 'The Improvement Effects and Mechanisms of Hemp Peptide in Patients with Non-Alcoholic Fatty Liver Disease' on June 27.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Medical College of Qingdao University
Condition:
Nonalcoholic fatty liver disease
Intervention:
Intervention Group:Hemp Peptide was administered orally at a dose of 3g daily for 12 weeks
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-28
Target Sample Size: Intervention Group:30;Control Group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/show...